Global Animal Intestinal Health Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Animal Intestinal Health Market is presumed to reach the market size of nearly USD 9.92 Billion by 2032 from USD 4.86 Billion in 2023 with a CAGR of 8.24% under the study period 2024-2032.

Animal intestinal health refers to the overall condition and functionality of the gastrointestinal tract in animals. It encompasses the balance of gut microbiota, effective nutrient absorption, immune system support, and the prevention of digestive disorders. A healthy intestinal system is crucial for optimal growth, reproduction, and resistance to diseases in livestock, poultry, and pets. This field focuses on enhancing gut health through feed additives, probiotics, prebiotics, and nutritional management strategies to improve animal performance and overall well-being.

Market Drivers

The animal intestinal health market is primarily driven by the growing demand for high-quality animal-derived products, increasing awareness about animal welfare, and the shift towards sustainable farming practices. Advancements in feed technology and the rising prevalence of gastrointestinal diseases also fuel market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Animal Intestinal Health. The growth and trends of Animal Intestinal Health industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Animal Intestinal Health market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Animal Type

Production Animal (Cattle, Swine, Poultry, Others (Sheep, Goats, Aquaculture, Etc.))
Companion Animal (Canine, Feline, Equine, Others (Turtles, Fish, Rabbits, Etc.))

By Product

Nutrition (Probiotics, Prebiotics, Postbiotics, Phytogenics, Enzymes, Immunomodulators)
Pharmaceuticals (Antibiotics, Others)

By Mode Of Delivery

Feed/Water Additives
Supplements & Tablets
Other Mode Of Delivery

By Function

Preventive Care
Disease Treatment

By Distribution Channel

Veterinary Hospitals/Clinics
Animal Farms
E-Commerce
Animal Specialty Stores
Other Distribution Channel

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Animal Intestinal Health market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Animal Intestinal Health market include Cargill, Evonik Industries, Kemin Industries, Alltech, Dsm-Firmenich (DSM), Adisseo, Kerry Group Plc., Novozymes A/S, Karyotica Biologicals Pvt Ltd., EW Nutrition, AB Vista, AdvaCarePharma, ADM, Zoetis, Boehringer Ingelheim, Dechra Pharmaceuticals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11214634

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ANIMAL INTESTINAL HEALTH - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Animal Type
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Mode Of Delivery
- 3.7.4 Market Attractiveness Analysis By Function
- 3.7.5 Market Attractiveness Analysis By Distribution Channel
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY ANIMAL TYPE

5.1. Overview By Animal Type
5.2. Historical and Forecast Data Analysis By Animal Type
5.3. Production Animal (Cattle, Swine, Poultry, Others (Sheep, Goats, Aquaculture, Etc.)) Historic and Forecast Sales By Regions
5.4. Companion Animal (Canine, Feline, Equine, Others (Turtles, Fish, Rabbits, Etc.)) Historic and Forecast Sales By Regions

6. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Nutrition (Probiotics, Prebiotics, Postbiotics, Phytogenics, Enzymes, Immunomodulators) Historic and Forecast Sales By Regions
6.4. Pharmaceuticals (Antibiotics, Others) Historic and Forecast Sales By Regions

7. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY MODE OF DELIVERY

7.1. Overview By Mode Of Delivery
7.2. Historical and Forecast Data Analysis By Mode Of Delivery
7.3. Feed/Water Additives Historic and Forecast Sales By Regions
7.4. Supplements & Tablets Historic and Forecast Sales By Regions
7.5. Other Mode Of Delivery Historic and Forecast Sales By Regions

8. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY FUNCTION

8.1. Overview By Function
8.2. Historical and Forecast Data Analysis By Function
8.3. Preventive Care Historic and Forecast Sales By Regions
8.4. Disease Treatment Historic and Forecast Sales By Regions

9. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY DISTRIBUTION CHANNEL

9.1. Overview By Distribution Channel
9.2. Historical and Forecast Data Analysis By Distribution Channel
9.3. Veterinary Hospitals/Clinics Historic and Forecast Sales By Regions
9.4. Animal Farms Historic and Forecast Sales By Regions
9.5. E-Commerce Historic and Forecast Sales By Regions
9.6. Animal Specialty Stores Historic and Forecast Sales By Regions
9.7. Other Distribution Channel Historic and Forecast Sales By Regions

10. GLOBAL ANIMAL INTESTINAL HEALTH MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE ANIMAL INTESTINAL HEALTH COMPANIES

11.1. Animal Intestinal Health Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF ANIMAL INTESTINAL HEALTH INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Cargill
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Evonik Industries
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Kemin Industries
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Alltech
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. Dsm-Firmenich (DSM)
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Adisseo
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Kerry Group Plc.
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Novozymes A/S
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. Karyotica Biologicals Pvt Ltd.
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. EW Nutrition
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments
12.13. AB Vista
- 12.13.1 Company Overview
- 12.13.2 Company Revenue
- 12.13.3 Products
- 12.13.4 Recent Developments
12.14. AdvaCarePharma
- 12.14.1 Company Overview
- 12.14.2 Company Revenue
- 12.14.3 Products
- 12.14.4 Recent Developments
12.15. ADM
- 12.15.1 Company Overview
- 12.15.2 Company Revenue
- 12.15.3 Products
- 12.15.4 Recent Developments
12.16. Zoetis
- 12.16.1 Company Overview
- 12.16.2 Company Revenue
- 12.16.3 Products
- 12.16.4 Recent Developments
12.17. Boehringer Ingelheim
- 12.17.1 Company Overview
- 12.17.2 Company Revenue
- 12.17.3 Products
- 12.17.4 Recent Developments
12.18. Dechra Pharmaceuticals
- 12.18.1 Company Overview
- 12.18.2 Company Revenue
- 12.18.3 Products
- 12.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies